• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Introduction to 2,5-Difluoro-4-(trifluoromethyl)benzoic acid (CAS No. 261945-05-5)

2,5-Difluoro-4-(trifluoromethyl)benzoic acid, identified by its Chemical Abstracts Service (CAS) number 261945-05-5, is a fluorinated benzoic acid derivative that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its two fluorine atoms at the 2- and 5-positions and a trifluoromethyl group at the 4-position, exhibits unique structural and electronic properties that make it a valuable intermediate in synthetic chemistry. The presence of multiple fluorine atoms enhances its lipophilicity and metabolic stability, which are critical factors in drug design.

Thesynthesis of 2,5-Difluoro-4-(trifluoromethyl)benzoic acid typically involves fluorination and trifluoromethylation reactions on a benzoic acid precursor. Advanced catalytic systems, such as transition metal-catalyzed cross-coupling reactions, have been employed to achieve high regioselectivity and yield. These synthetic approaches are in line with the growing demand for efficient and sustainable methodologies in chemical manufacturing.

Recent studies have highlighted thepharmacological potential of 2,5-Difluoro-4-(trifluoromethyl)benzoic acid as a lead compound for developing novel therapeutic agents. Its structural motif is reminiscent of known bioactive molecules, suggesting potential applications in areas such as anti-inflammatory, anti-viral, and anticancer therapies. For instance, fluorinated benzoic acids have been reported to modulate enzyme activity by influencing binding affinities and metabolic pathways.

In particular, thetrifluoromethyl group is a well-documented pharmacophore that enhances binding interactions with biological targets. This feature has been exploited in the design of drugs with improved pharmacokinetic profiles. Additionally, thefluoro substituents contribute to the compound's stability against enzymatic degradation, extending its half-life in vivo. These attributes make 2,5-Difluoro-4-(trifluoromethyl)benzoic acid an attractive candidate for further development.

Theagrochemical industry has also shown interest in this compound due to its potential as a precursor for next-generation pesticides. Fluorinated aromatic compounds often exhibit enhanced efficacy against resistant pests while maintaining environmental safety. Research is ongoing to explore its role in synthesizing novel herbicides and fungicides that address emerging challenges in crop protection.

Theanalytical characterization of 2,5-Difluoro-4-(trifluoromethyl)benzoic acid is typically performed using high-resolution mass spectrometry (HRMS), nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography. These techniques provide definitive confirmation of its molecular structure and purity. Furthermore, computational methods such as density functional theory (DFT) have been utilized to predict its electronic properties and reactivity.

In conclusion, 2,5-Difluoro-4-(trifluoromethyl)benzoic acid (CAS No. 261945-05-5) represents a promising compound with diverse applications across pharmaceuticals and agrochemicals. Its unique structural features and favorable physicochemical properties position it as a key intermediate in drug discovery and material science. As research continues to uncover new synthetic routes and biological activities, this compound is poised to play an increasingly significant role in modern chemistry.

• 157337-81-0(2,4-Difluoro-3-(trifluoromethyl)benzoic Acid)
• 115029-23-7(2-Fluoro-5-(trifluoromethyl)benzoic acid)
• 118829-14-4(Benzoic acid,2,4,5-trifluoro-3-(trifluoromethyl)-)
• 5216-22-8(2,3,5,6-Tetrafluoro-4-(trifluoromethyl)benzoic Acid)
• 203915-94-0(Benzoic acid,2,3,4-trifluoro-5-(trifluoromethyl)-)
• 115029-24-8(2-Fluoro-4-(trifluoromethyl)benzoic acid)
• 261945-09-9(3,5-Difluoro-4-(trifluoromethyl)benzoic acid)
• 237424-17-8(2,3-Difluoro-4-(trifluoromethyl)benzoic acid)
• 115029-22-6(2-Fluoro-3-(trifluoromethyl)benzoic acid)
• 115754-21-7(3-Fluoro-4-(trifluoromethyl)benzoic acid)